Anthropic wants to develop its own drugs
The Verge: Anthropic is now saying it wants to develop its own drug candidates on top of the Claude Science workbench.
Why it matters
- Largest extension of Claude Science since Tuesday's launch — moves from workflow-provider to drug-developer.
- Direct challenge to Isomorphic Labs and the Google-DeepMind therapeutics angle.
- Materially expands Anthropic's addressable market beyond dev tools and inference.
- Sets a new frontier-lab template: sell the workbench, then use it yourself.